Several new blood-based tests can help physicians detect Alzheimer’s disease years before symptoms become debilitating, but because they’re considered screening tests, they’re not covered by Medicare.  This leaves millions of Americans undiagnosed or forced to wait until more serious symptoms appear. That means less time for early interventions, lifestyle and diet changes, or for anti-amyloid…